Is cannabis actually effective as a pain management tool or is it all just placebo? How does the media portrayal of cannabis research impact research? In part II of the cannabis series, we are joined by Dr. Filip Gedin, a postdoc in the Pain Neuroimaging Lab at Karolinska Institutet in Sweden. Dr. Gedin obtained his Ph.D. in health economics from Karolinska Institutet in 2020. In his PhD thesis, he explored the costs associated with back pain and the effectiveness of primary care interventions for individuals with persistent low back pain through systematic reviews, clinical trials, and register-based studies. He has previously worked at the Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) as a health economist. SBU is tasked by the government with assessing healthcare and social service interventions via the use of systematic reviews. The focus of his postdoctoral research is to further understand how chronic pain develops through the PrePain project, along with continuing to evaluate treatments for pain.
Authors: Elena Koning
Dr. Filip Gedin's Lab Instagram: https://www.instagram.com/kipainandbrain/
Email: thinktwicepodcast@outlook.com
Instagram: @thinktwice_podcast
Patreon: https://www.patreon.com/ThinkTwicePodcast
Disclaimer: Think Twice is a podcast for general information and entertainment purposes only. The content discussed in the episodes does not reflect the views of the podcast committee members or any institution they are affiliated with. The use of the information presented in this podcast is at the user’s own risk and is not intended to replace professional healthcare services.
